Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HDAC1 | Q13547 | 1/20 | 0.40 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.40 |
| ▸ | MMP3 | P08254 | 6/20 | 0.39 |
| ▸ | MMP2 | P08253 | 6/20 | 0.38 |
| ▸ | PTPN2 | P17706 | 3/20 | 0.36 |
| ▸ | PTPN1 | P18031 | 3/20 | 0.36 |
| ▸ | MAPT | P10636 | 2/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.36 |
| ▸ | MMP1 | P03956 | 1/20 | 0.36 |
| ▸ | MMP9 | P14780 | 1/20 | 0.36 |
| ▸ | MMP13 | P45452 | 1/20 | 0.36 |
| ▸ | CYSLTR1 | Q9Y271 | 1/20 | 0.35 |
| ▸ | HTT | P42858 | 1/20 | 0.35 |
| ▸ | THRB | P10828 | 1/20 | 0.34 |
| ▸ | HRH2 | P25021 | 1/20 | 0.34 |
| ▸ | HRH1 | P35367 | 1/20 | 0.34 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.34 |
| ▸ | PTPN11 | Q06124 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25269639 | 1.00 | HDAC1 (0.40) | HDAC1HDAC2MMP3MMP2PTPN2 | |
| SCHEMBL30457662 | 1.00 | HDAC1 (0.40) | HDAC1HDAC2MMP3MMP2PTPN2 | |
| SCHEMBL25227956 | 1.00 | HDAC1 (0.40) | HDAC1HDAC2MMP3MMP2PTPN2 | |
| SCHEMBL25226273 | 1.00 | HDAC1 (0.40) | HDAC1HDAC2MMP3MMP2PTPN2 | |
| SCHEMBL30457539 | 1.00 | HDAC1 (0.40) | HDAC1HDAC2MMP3MMP2PTPN2 | |
| SCHEMBL25276683 | 0.99 | HDAC1 (0.40) | HDAC1HDAC2MMP3MMP2PTPN2 | |
| SCHEMBL30457044 | 0.99 | HDAC1 (0.40) | HDAC1HDAC2MMP3MMP2PTPN2 | |
| SCHEMBL4333267 | 0.97 | MAPT (0.38) | HDAC1HDAC2MMP3PTPN2PTPN1 | |
| SCHEMBL496334 | 0.97 | HDAC1 (0.42) | HDAC1HDAC2MMP3MMP2PTPN2 | |
| SCHEMBL4335911 | 0.97 | HDAC1 (0.42) | HDAC1HDAC2MMP3MMP2PTPN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12534670-B2 | Liquid crystal compounds | Rolic Technologies AG (CH) | 2026-01-27 | — | — | US | disclosed |
| US-20250066666-A1 | LIQUID CRYSTAL COMPOUNDS | Rolic Technologies AG (CH) | 2025-02-27 | — | — | US | disclosed |
| EP-4444822-A1 | LIQUID CRYSTAL COMPOUNDS | Rolic Technologies AG (CH) | 2024-10-16 | — | — | EP | disclosed |
| WO-2023104545-A1 | LIQUID CRYSTAL COMPOUNDS | Rolic Technologies AG (CH) | 2023-06-15 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12534670-B2 | Liquid crystal compounds | SCO2, LBR, C1R | HDAC1 4042/4885HDAC2 3701/4885MMP3 2736/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.